Title of article :
Effect on dyspnoea and hypoxaemia of inhaled NG-nitro-L-arginine methyl ester in hepatopulmonary syndrome
Author/Authors :
Luisa Brussino، نويسنده , , C Bucca، نويسنده , , M Morello، نويسنده , , Ilaria Scappaticci، نويسنده , , M Mauro، نويسنده , , G Rolla، نويسنده ,
Issue Information :
روزنامه با شماره پیاپی سال 2003
Pages :
2
From page :
43
To page :
44
Abstract :
Hepatopulmonary syndrome—a complication of chronic liver disease—is characterised by hypoxaemia, which results from widespread intrapulmonary vascular dilatations. Amplified production of pulmonary nitric oxide is thought to be important in development of this disorder in patients with liver cirrhosis. Here, we report a 64-year-old man with hepatopulmonary syndrome associated with hepatitis-C-virusrelated cirrhosis. We gave the patient nebulised NG-nitro-L-arginine methyl ester (L-NAME), an inhibitor of NO synthesis, which enhanced oxygenation (arterial oxygen pressure increased from 6•98 to 9•45 kPa). After L-NAME, the distance the patient could walk in 6 min rose by 92 m. Administration of L-NAME by aerosol might offer a new approach to treatment of hepatopulmonary syndrome.
Journal title :
The Lancet
Serial Year :
2003
Journal title :
The Lancet
Record number :
559245
Link To Document :
بازگشت